Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Momordica charantia | 9 | 2019 | 17 | 2.840 |
Why?
|
| Plant Extracts | 9 | 2015 | 302 | 1.570 |
Why?
|
| Morinda | 2 | 2015 | 9 | 0.830 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 184 | 0.700 |
Why?
|
| Liver | 3 | 2011 | 511 | 0.700 |
Why?
|
| Vitamin B 12 | 1 | 2021 | 23 | 0.680 |
Why?
|
| Coffee | 1 | 2021 | 20 | 0.680 |
Why?
|
| Drinking | 1 | 2021 | 37 | 0.680 |
Why?
|
| Folic Acid | 1 | 2021 | 49 | 0.680 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2015 | 760 | 0.570 |
Why?
|
| Beverages | 2 | 2011 | 66 | 0.570 |
Why?
|
| Adipose Tissue | 2 | 2019 | 182 | 0.560 |
Why?
|
| Lipid Metabolism | 2 | 2010 | 148 | 0.520 |
Why?
|
| Kava | 2 | 2007 | 6 | 0.470 |
Why?
|
| Lactones | 2 | 2007 | 23 | 0.470 |
Why?
|
| Alkaloids | 2 | 2007 | 46 | 0.450 |
Why?
|
| Pyridones | 2 | 2007 | 50 | 0.450 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 78 | 0.430 |
Why?
|
| Phytotherapy | 2 | 2011 | 75 | 0.420 |
Why?
|
| Dietary Fats | 2 | 2011 | 117 | 0.400 |
Why?
|
| Oxidative Stress | 2 | 2011 | 1003 | 0.390 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2013 | 134 | 0.370 |
Why?
|
| Gluconeogenesis | 1 | 2011 | 15 | 0.360 |
Why?
|
| Glycolysis | 1 | 2011 | 71 | 0.350 |
Why?
|
| Obesity | 3 | 2021 | 1151 | 0.340 |
Why?
|
| Encephalitis | 1 | 2011 | 43 | 0.340 |
Why?
|
| Cucurbitaceae | 2 | 2013 | 6 | 0.330 |
Why?
|
| Adipogenesis | 1 | 2010 | 14 | 0.330 |
Why?
|
| Plant Preparations | 1 | 2010 | 24 | 0.320 |
Why?
|
| Genes, cdc | 1 | 2010 | 8 | 0.320 |
Why?
|
| Adipocytes | 1 | 2010 | 60 | 0.310 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 141 | 0.310 |
Why?
|
| Anticarcinogenic Agents | 1 | 2010 | 77 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 1869 | 0.300 |
Why?
|
| Apolipoproteins B | 2 | 2006 | 18 | 0.290 |
Why?
|
| Apolipoprotein B-100 | 1 | 2008 | 7 | 0.280 |
Why?
|
| Receptor, Insulin | 1 | 2008 | 25 | 0.280 |
Why?
|
| Transcription Factors | 2 | 2010 | 735 | 0.270 |
Why?
|
| Carrier Proteins | 2 | 2010 | 321 | 0.260 |
Why?
|
| RNA, Messenger | 5 | 2011 | 1271 | 0.250 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2007 | 98 | 0.250 |
Why?
|
| HIV Protease Inhibitors | 1 | 2006 | 24 | 0.250 |
Why?
|
| Animals | 12 | 2019 | 16992 | 0.240 |
Why?
|
| Random Allocation | 3 | 2011 | 147 | 0.240 |
Why?
|
| Microsomes | 1 | 2005 | 55 | 0.230 |
Why?
|
| Apoptosis | 3 | 2011 | 1568 | 0.230 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2006 | 163 | 0.210 |
Why?
|
| Acidosis, Lactic | 1 | 2003 | 6 | 0.210 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 213 | 0.200 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 224 | 0.200 |
Why?
|
| Cell Line, Tumor | 6 | 2013 | 2676 | 0.190 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2003 | 229 | 0.190 |
Why?
|
| West Nile Fever | 2 | 2014 | 68 | 0.190 |
Why?
|
| West Nile virus | 2 | 2014 | 78 | 0.180 |
Why?
|
| Humans | 14 | 2021 | 43102 | 0.180 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 127 | 0.160 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 263 | 0.160 |
Why?
|
| Mice | 7 | 2014 | 6644 | 0.150 |
Why?
|
| Fruit | 2 | 2011 | 178 | 0.150 |
Why?
|
| Panniculitis | 1 | 2019 | 2 | 0.150 |
Why?
|
| Body Weight | 2 | 2019 | 429 | 0.150 |
Why?
|
| Freeze Drying | 1 | 2019 | 29 | 0.150 |
Why?
|
| Phenotype | 2 | 2021 | 780 | 0.150 |
Why?
|
| Adipokines | 1 | 2019 | 28 | 0.150 |
Why?
|
| Male | 7 | 2021 | 23409 | 0.150 |
Why?
|
| Neoplasms | 1 | 2010 | 1377 | 0.150 |
Why?
|
| Superoxide Dismutase | 2 | 2011 | 158 | 0.140 |
Why?
|
| Overweight | 1 | 2021 | 249 | 0.140 |
Why?
|
| Female | 7 | 2021 | 24698 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3156 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1723 | 0.140 |
Why?
|
| Colon | 1 | 2019 | 120 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 161 | 0.140 |
Why?
|
| Caspases | 2 | 2010 | 148 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2021 | 925 | 0.130 |
Why?
|
| Adolescent | 3 | 2021 | 6081 | 0.120 |
Why?
|
| Dietary Supplements | 2 | 2011 | 213 | 0.120 |
Why?
|
| Brain | 3 | 2014 | 1472 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1070 | 0.120 |
Why?
|
| Young Adult | 2 | 2021 | 5080 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1081 | 0.110 |
Why?
|
| DNA Primers | 2 | 2006 | 294 | 0.110 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2007 | 28 | 0.110 |
Why?
|
| Plant Leaves | 2 | 2007 | 136 | 0.110 |
Why?
|
| Macrophages | 1 | 2019 | 529 | 0.110 |
Why?
|
| Biological Products | 1 | 2015 | 91 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 9 | 0.100 |
Why?
|
| Base Sequence | 2 | 2006 | 983 | 0.100 |
Why?
|
| Leukocytes | 1 | 2014 | 80 | 0.100 |
Why?
|
| Cell Cycle | 2 | 2013 | 346 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 81 | 0.100 |
Why?
|
| Immunity | 1 | 2012 | 61 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 186 | 0.090 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2011 | 13 | 0.090 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 63 | 0.090 |
Why?
|
| Middle Aged | 2 | 2021 | 12222 | 0.090 |
Why?
|
| Taste | 1 | 2011 | 45 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 34 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 64 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1604 | 0.080 |
Why?
|
| Catalase | 1 | 2011 | 110 | 0.080 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 112 | 0.080 |
Why?
|
| Time Factors | 2 | 2007 | 1857 | 0.080 |
Why?
|
| Protein Transport | 1 | 2011 | 296 | 0.080 |
Why?
|
| RNA Interference | 1 | 2011 | 247 | 0.080 |
Why?
|
| Lipogenesis | 1 | 2010 | 19 | 0.080 |
Why?
|
| Adult | 2 | 2021 | 13872 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 185 | 0.080 |
Why?
|
| Vegetables | 1 | 2011 | 147 | 0.080 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 43 | 0.080 |
Why?
|
| Phenols | 1 | 2011 | 107 | 0.080 |
Why?
|
| G2 Phase | 1 | 2010 | 28 | 0.080 |
Why?
|
| Cytokines | 1 | 2014 | 678 | 0.080 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 34 | 0.080 |
Why?
|
| Enzyme Induction | 2 | 2007 | 52 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1596 | 0.080 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 173 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 95 | 0.080 |
Why?
|
| Cell Division | 1 | 2010 | 311 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2011 | 389 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2010 | 462 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 652 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2010 | 206 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2011 | 986 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2011 | 760 | 0.070 |
Why?
|
| Apolipoprotein B-48 | 1 | 2008 | 7 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2011 | 269 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 241 | 0.070 |
Why?
|
| Antioxidants | 1 | 2011 | 443 | 0.070 |
Why?
|
| Rhizome | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cytochromes | 1 | 2007 | 5 | 0.070 |
Why?
|
| Mitochondria, Liver | 1 | 2007 | 15 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2007 | 24 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2007 | 20 | 0.060 |
Why?
|
| Diet | 2 | 2011 | 826 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2010 | 638 | 0.060 |
Why?
|
| Apolipoprotein C-III | 1 | 2006 | 7 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2007 | 258 | 0.060 |
Why?
|
| Apolipoprotein A-I | 1 | 2006 | 24 | 0.060 |
Why?
|
| Glutathione | 1 | 2007 | 171 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2008 | 201 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 138 | 0.060 |
Why?
|
| Oleic Acid | 1 | 2005 | 15 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 26 | 0.060 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2005 | 12 | 0.060 |
Why?
|
| Cytosol | 1 | 2005 | 97 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 384 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2007 | 536 | 0.050 |
Why?
|
| Plant Stems | 1 | 2004 | 12 | 0.050 |
Why?
|
| Pyrones | 1 | 2004 | 11 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 532 | 0.050 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2003 | 57 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 54 | 0.050 |
Why?
|
| Nucleosides | 1 | 2003 | 30 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 222 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 234 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2005 | 383 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2003 | 112 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 206 | 0.050 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2002 | 26 | 0.050 |
Why?
|
| Meat | 1 | 2002 | 46 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1092 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 561 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1124 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 665 | 0.040 |
Why?
|
| Mitochondria | 1 | 2003 | 523 | 0.040 |
Why?
|
| Rats | 1 | 2007 | 3735 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 968 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 734 | 0.040 |
Why?
|
| Aged | 1 | 2011 | 8214 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2002 | 512 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1455 | 0.030 |
Why?
|
| Smoking | 1 | 2002 | 1024 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2014 | 14 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 83 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2014 | 127 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 204 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2012 | 76 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2012 | 43 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 75 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 40 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 347 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 101 | 0.020 |
Why?
|
| Chemokines | 1 | 2012 | 96 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 694 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 286 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 386 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 114 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 368 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 695 | 0.020 |
Why?
|
| Viral Load | 1 | 2012 | 348 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 260 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 508 | 0.020 |
Why?
|
| Prostate | 1 | 2011 | 155 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 655 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2012 | 306 | 0.020 |
Why?
|
| Virus Replication | 1 | 2012 | 318 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 883 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 667 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 1263 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 2157 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2002 | 124 | 0.010 |
Why?
|
| Registries | 1 | 2002 | 437 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 800 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1285 | 0.010 |
Why?
|
| Hawaii | 1 | 2002 | 2011 | 0.010 |
Why?
|
| Risk Factors | 1 | 2002 | 3994 | 0.010 |
Why?
|